Eye News and Research

Latest Eye News and Research

Probability of blindness from glaucoma drops by half, say researchers

A comparative long-range study by Mayo Clinic ophthalmology researchers shows that the probability of blindness from glaucoma 20 years after diagnosis has dropped by half in the last generation. The findings appear online in the "in press" section of the journal Ophthalmology.

22 Jan 2014

Abortion rights fight central to midterm election races

Abortion rights have yet again become a central issue in midterm elections while an order of nuns finds itself in the center of the health law's contraception coverage mandate.

22 Jan 2014

Study: Probability of blindness due to glaucoma has decreased by nearly half

The probability of blindness due to the serious eye disease glaucoma has decreased by nearly half since 1980, according to a study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. The researchers speculate that advances in diagnosis and therapy are likely causes for the decrease, but caution that a significant proportion of patients still progress to blindness.

21 Jan 2014

It Works! Global announces launch of first chewable dietary supplement

It Works! Global, a wellness products and lifestyle company, announced the launch of Greens Chew, a dietary supplement for antioxidant and prebiotic support.

21 Jan 2014

First Edition: January 21, 2014

Today's headlines include news on the health law's implementation at both the federal and state levels.

21 Jan 2014

Sleeping position influences glaucoma visual loss

Researchers from South Korea suggest that patients with glaucoma should avoid sleeping on one side, after showing that it may be associated with greater visual field loss in the lower-positioned eye.

20 Jan 2014

Eye Center of Central PA goes live with Medflow EHR

Medflow is pleased to announce the first successful deployment of Medflow version 8.1, the company's 2014 Meaningful Use Certified version. This is a tremendous milestone and accomplishment that demonstrates the leadership role Medflow maintains in the eye care industry.

19 Jan 2014

Docs, hospitals cope with 'trickle' of newly insured patients -- but questions continue about the actual number

As the Wall Street Journal reports that one of the biggest issues right now is making sure these newly insured people have insurance cards, other news outlets detail reports and questions about the number of enrollees.

17 Jan 2014

Viewpoints: Mass. abortion debate comes down to 35 feet; Tampa mayor leads charge to get young people signed up for health care

The First Amendment protects the speech of short, elderly women and large and intimidating men equally, but you would be forgiven for thinking otherwise after oral arguments before the Supreme Court Wednesday morning.

17 Jan 2014

Cedars-Sinai researcher to receive 2014 Troland Research Award

Ueli Rutishauser, PhD, assistant professor of neurosurgery and director of human neurophysiology research in the Department of Neurosurgery and the Department of Neurology at Cedars-Sinai, will receive a 2014 Troland Research Award at the National Academy of Sciences annual meeting April 27.

16 Jan 2014

New gene therapy restores some sight in people born with inherited form of blindness

A new gene therapy has restored some sight in people born with an inherited, progressive form of blindness. The technique replaces a defective gene in the eye with a normal working copy of the gene using a single injection.

16 Jan 2014

First Edition: January 16, 2013

Today's headlines include reports that a federal judge on Wednesday rejected a legal challenge related to the health law's insurance subsidies.

16 Jan 2014

Neuroscientists find human brain can process entire images that eye sees for 13 milliseconds

Imagine seeing a dozen pictures flash by in a fraction of a second. You might think it would be impossible to identify any images you see for such a short time.

16 Jan 2014

Cedars-Sinai investigators identify new molecular abnormalities in diabetic cornea

Investigators at the Cedars-Sinai Regenerative Medicine Institute have identified new molecular abnormalities in the diabetic cornea that could contribute to eye problems in affected patients.

16 Jan 2014

State legislators contemplate flaws in New York's online insurance marketplace

Testimony during a New York State Senate hearing Monday explored problems that have emerged during the rollout of New York State of Health. News outlets also reported the latest related developments from Maryland and California.

15 Jan 2014

Cedars-Sinai investigators identify new molecular abnormalities in diabetic cornea

Investigators at the Cedars-Sinai Regenerative Medicine Institute have identified new molecular abnormalities in the diabetic cornea that could contribute to eye problems in affected patients. With this new knowledge, investigators aim to accelerate the process of healing and repair in damaged corneas to ultimately reverse the effects of diabetes-induced eye complications.

15 Jan 2014

Study shows wide-ranging variation in patterns of X chromosome inactivation in female mice

Producing brightly speckled red and green snapshots of many different tissues, Johns Hopkins researchers have color-coded cells in female mice to display which of their two X chromosomes has been made inactive, or “silenced.”

10 Jan 2014

Colgate offers easy-to-follow tips to help women stay on track for better, healthy lifestyle this year

The start of a new year is often a time for reflection and a resolve to change. Whether the resolutions are big or small, most people by now are already starting down the path to a new and better version of themselves.

10 Jan 2014

FDA approves Ocular Therapeutix’s ReSure Sealant for ophthalmic use

Ocular Therapeutix announced today it has received approval from the Food and Drug Administration to commercialize the ReSure Sealant in the United States, with an indication for prevention of postoperative fluid egress from incisions with a demonstrated wound leak following cataract surgery.

10 Jan 2014

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.

9 Jan 2014

Eye News and Research

Latest Eye News and Research

Probability of blindness from glaucoma drops by half, say researchers

Abortion rights fight central to midterm election races

Study: Probability of blindness due to glaucoma has decreased by nearly half

It Works! Global announces launch of first chewable dietary supplement

First Edition: January 21, 2014

Sleeping position influences glaucoma visual loss

Eye Center of Central PA goes live with Medflow EHR

Docs, hospitals cope with 'trickle' of newly insured patients -- but questions continue about the actual number

Viewpoints: Mass. abortion debate comes down to 35 feet; Tampa mayor leads charge to get young people signed up for health care

Cedars-Sinai researcher to receive 2014 Troland Research Award

New gene therapy restores some sight in people born with inherited form of blindness

First Edition: January 16, 2013

Neuroscientists find human brain can process entire images that eye sees for 13 milliseconds

Cedars-Sinai investigators identify new molecular abnormalities in diabetic cornea

State legislators contemplate flaws in New York's online insurance marketplace

Cedars-Sinai investigators identify new molecular abnormalities in diabetic cornea

Study shows wide-ranging variation in patterns of X chromosome inactivation in female mice

Colgate offers easy-to-follow tips to help women stay on track for better, healthy lifestyle this year

FDA approves Ocular Therapeutix’s ReSure Sealant for ophthalmic use

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Eye News and Research

Latest Eye News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in